securities fraud

Class action lawsuit filed against $MDPC alleges false statements inflated share price. Investors who bought stock between April 2025 and February 2026 may be eligible.

Coty Inc. faces class action securities fraud lawsuit for allegedly concealing deteriorating beauty and fragrance business conditions while projecting $1 billion EBITDA, resulting in 22% stock decline.

$DRVN stock plunges 40% after revealing multi-year accounting errors and material control weaknesses despite prior management certifications. Securities class action lawsuit filed.

ADMA Biologics faces securities investigation for alleged channel stuffing. Stock fell 16.6% after allegations; class action lawsuit being prepared.

Stellantis faces class action lawsuit alleging management concealed €22B restructuring needs. Stock plunged 23.69% after February 2026 disclosure of charges and business reset.

Federal securities lawsuit filed against Babcock & Wilcox for alleged misstatements regarding power generation contract. Stock fell 11.59% after conflict-of-interest report.

Class action lawsuit filed against $RGC for failing to disclose market manipulation vulnerabilities. June 23, 2026 deadline for lead plaintiff claims.

Class action lawsuit filed against zSpace alleging false IPO statements regarding preferred shareholders and litigation risks. Lead plaintiff deadline set for June 22, 2026.

Law firm files class action against Regencell Bioscience ($RGC) alleging false statements about market manipulation risks. Investors urged to join case by June 23, 2026 deadline.

Law firm Johnson Fistel investigates POET Technologies after Marvell Semiconductor canceled all orders from subsidiary Celestial AI due to confidentiality breaches, triggering material stock decline.

Vital Farms faces class action lawsuit alleging ERP implementation risks were downplayed, leading to missed 2025 earnings guidance and investor losses.

Class action lawsuit filed against Gossamer Bio for allegedly concealing design flaws in Phase 3 PROSERA study, claiming investors purchased stock at artificially inflated prices.

Class action lawsuit filed against $UPST alleging false statements about Model 22 AI underwriting capabilities and inflated performance metrics.

Class action lawsuit filed against $AQST alleging securities fraud over false FDA timeline statements and concealed safety risks for Anaphylm drug.

Bronstein, Gewirtz & Grossman files class action against $ATAR, alleging executives misled investors about manufacturing issues and FDA approval prospects for tabelecleucel.

Class action filed against $GO alleging securities fraud over false financial statements and unsustainable expansion strategy requiring major restructuring.

Class action lawsuit filed against Camping World Holdings alleging securities fraud over false inventory management statements and overstated consumer demand between April 2025 and February 2026.

Soleno Therapeutics faces class action lawsuit over allegedly undisclosed fluid retention safety issues with DCCR drug candidate during March-November 2025 period.

Sportradar faces securities fraud investigation after Muddy Waters alleges ties to 50+ illegal gambling operations. Stock falls 22%.

Law firm investigating Twenty One Capital ($XXI) for potential securities violations including false statements and material information disclosure failures.